Temozolomide

1. What is Temozolomide?

Temozolomide is a prescription medication that belongs to a class of drugs called alkylating agents, a type of chemotherapy. It works by damaging the genetic material (DNA) of rapidly dividing cells, which helps slow or stop the growth of certain cancers.

Temozolomide is commonly prescribed for:

• Newly diagnosed glioblastoma multiforme, typically used together with radiation therapy and then continued alone
• Anaplastic astrocytoma that has recurred or progressed after other treatments
• Other brain tumors, in certain clinical situations, as determined by an oncology specialist

Available formulations: Temozolomide is available as an oral capsule in several different strengths, and in some settings as a powder for intravenous infusion. Patients should confirm the exact formulation and strength prescribed with their treating specialist and pharmacist.

2. What is the Recommended Dosage of Temozolomide?

Dosage of temozolomide is highly individualized and depends on several factors, including:

• The specific type and stage of the brain tumor being treated
• Whether it is being used together with radiation therapy or on its own
• Body surface area, which is calculated from height and weight
• Blood cell counts, since temozolomide can affect bone marrow function
• Liver and kidney function
• Response to previous treatment cycles and any side effects experienced

Because dosing is calculated individually based on body surface area and treatment phase, and because treatment typically follows specific cycles, this page does not provide specific dosing numbers. Only a licensed oncologist or neuro-oncologist can determine the correct dose, schedule, and number of treatment cycles for a given patient. Never adjust the dose or skip planned lab monitoring without medical guidance.

3. How Temozolomide Works

Temozolomide works by adding chemical groups to the DNA of cells (a process called alkylation), which damages the DNA of rapidly dividing cells, including cancer cells. This damage interferes with the cancer cells’ ability to divide and grow, and can lead to cancer cell death.

Because temozolomide affects rapidly dividing cells generally, it can also affect some healthy cells that divide quickly, such as those in the bone marrow, which is why regular blood count monitoring is an important part of treatment.

Temozolomide manages certain brain tumors as part of a broader treatment plan; whether it is used with the goal of long-term control, or in combination with other treatments such as radiation and surgery, is determined individually by the treating oncology team based on the specific diagnosis.

4. Is a Prescription Required to Buy Temozolomide Online?

Yes. Temozolomide is a prescription-only medication and cannot be legally purchased without a valid prescription from a licensed healthcare provider.

Given that temozolomide is a chemotherapy medication used to treat serious brain tumors, it should only be prescribed and closely monitored by a licensed oncologist or neuro-oncologist, who can evaluate the diagnosis, calculate the appropriate dose, monitor blood counts and organ function, and manage side effects throughout treatment.

Patients should be cautious of:

• Websites offering temozolomide without a prescription
• Unusually low prices, which may indicate counterfeit or substandard products
• Products marketed for veterinary or non-human use
• Sellers that are not licensed pharmacies

Temozolomide should only be obtained from a licensed pharmacy, using a valid prescription, to ensure the product is safe, authentic, and correctly dosed, and that it is handled according to chemotherapy safety guidelines.

5. Side Effects of Temozolomide

Common Side Effects

These are often expected with chemotherapy treatment and should still be discussed with the oncology team:

• Nausea and vomiting
• Fatigue
• Constipation or diarrhea
• Loss of appetite
• Headache
• Hair thinning or hair loss

Serious Side Effects

Some side effects are less common but require prompt medical attention:

• Signs of low blood cell counts (unusual bruising or bleeding, frequent infections, fever, severe fatigue or paleness)
• Signs of liver problems (yellowing of the skin or eyes, dark urine, severe fatigue, loss of appetite)
• Signs of a severe allergic reaction (swelling of the face, lips, or throat; difficulty breathing; severe rash)
• Signs of a serious lung problem, particularly when used with radiation therapy (new or worsening shortness of breath, persistent cough)
• Signs of a rare but serious infection called Pneumocystis pneumonia, particularly during combined treatment with radiation
• Severe or persistent vomiting that prevents keeping food or fluids down

Patients or caregivers should seek immediate medical attention if any of these serious symptoms occur. This list is not exhaustive, and any new or worsening symptoms should be reported to the oncology team promptly, as chemotherapy side effects can sometimes become serious quickly.

6. Drug Interactions

Temozolomide can interact with a range of other medications and substances, including:

• Other medications that affect bone marrow function or blood cell counts, which may increase the risk of low blood counts
• Certain anti-seizure medications, which are commonly used in patients with brain tumors and may require dose adjustments
• Live vaccines, which are generally avoided during chemotherapy treatment due to a weakened immune response
• Over-the-counter medications, including certain pain relievers that can increase bleeding risk
• Herbal products and dietary supplements, some of which may affect how the body processes chemotherapy medications

Patients should provide their oncology specialist and pharmacist with a complete and current list of all prescription medications, over-the-counter drugs, vitamins, and herbal supplements before starting temozolomide and throughout treatment.

7. Safety & Important Considerations

• Bone marrow suppression: Temozolomide can significantly lower blood cell counts, increasing the risk of infection, bleeding, and anemia. Regular blood count monitoring is a required part of treatment.
• Liver function: Periodic liver function testing is typically recommended before and during treatment.
• Pregnancy and breastfeeding: Temozolomide can cause serious harm to a developing fetus and is generally not used during pregnancy. Effective contraception is typically recommended for patients who can become pregnant or father a child during and for a period after treatment. Breastfeeding is generally not recommended during treatment.
• Fertility: Temozolomide may affect fertility in some patients; this should be discussed with the oncology team before starting treatment, particularly for patients who wish to have children in the future.
• Age-related considerations: Temozolomide is used in both adults and, in certain situations, children with specific brain tumors, under close specialist supervision. Older adults may require closer monitoring for side effects.
• Handling precautions: As a chemotherapy medication, temozolomide capsules should not be opened or crushed, and caregivers should follow specific handling and disposal instructions provided by the pharmacy or care team.
• Monitoring requirements: Regular blood tests (complete blood counts), liver function tests, and imaging to assess treatment response are typically required throughout therapy.
• Secondary cancer risk: As with many chemotherapy medications, there is a small risk of other blood-related cancers developing after treatment; this risk is discussed by the oncology team as part of informed treatment decisions.

This medication should be used only for its approved indications, as determined by the prescribing oncology specialist.

8. Who This Medication Is For

Temozolomide is typically prescribed for patients diagnosed with specific types of brain tumors, most commonly newly diagnosed glioblastoma multiforme (usually combined with radiation therapy) or recurrent anaplastic astrocytoma. It is used in both adult and, in select cases, pediatric patients, based on diagnosis and evaluation by an oncology specialist.

9. Who Should Not Take Temozolomide

Temozolomide may not be appropriate for individuals who:

• Have a known hypersensitivity or allergic reaction to temozolomide or related medications (such as dacarbazine)
• Have severely low blood cell counts at the start of a treatment cycle, unless cleared by the oncology team
• Are pregnant, due to the risk of serious harm to a developing fetus
• Have severe liver impairment, unless specifically directed and closely monitored by a specialist

This is not a complete list of contraindications. A licensed oncology specialist must review a patient’s full medical history and current blood counts before prescribing or continuing temozolomide.

10. What to Do If You Miss a Dose

If a dose of temozolomide is missed, patients or caregivers should contact the treating oncology team as soon as possible for specific guidance, since temozolomide is typically taken on a precise cycle schedule (often a set number of days on treatment followed by a rest period) that is individually calculated.

Patients should never take an extra dose or double up without direct instruction from the oncology team, as chemotherapy dosing errors can have serious consequences.

Alternatives to Temozolomide

Alternatives to Temozolomide depend on the tumor type, grade, recurrence status, and molecular markers such as MGMT, IDH, BRAF, and 1p/19q status. Temozolomide is commonly used for glioblastoma and some gliomas, so it should not be replaced without an oncology plan.

Alternatives to Temozolomide

Use Case	Possible Alternatives	Notes
Glioblastoma — newly diagnosed	Radiation therapy, carmustine implant, Tumor Treating Fields, clinical trial options	Standard treatment often includes surgery, radiation, and temozolomide; NCI lists carmustine-impregnated implant and radiation-based approaches among glioblastoma treatment options. (Cancer.gov)
Recurrent glioblastoma	Lomustine, Bevacizumab, Carmustine, Regorafenib, clinical trial therapy	These may be considered when glioblastoma returns after temozolomide-based treatment. Bevacizumab, lomustine, and carmustine are listed among FDA-approved brain tumor drugs by NCI. (Cancer.gov)
Low-grade / high-risk glioma	PCV regimen: Procarbazine + Lomustine + Vincristine	PCV is a common chemotherapy combination for some gliomas and may be used instead of or after temozolomide depending on tumor type and markers. Cancer Research UK lists PCV and temozolomide as common chemotherapy options for brain tumors. (Cancer Research UK)
Oligodendroglioma with 1p/19q codeletion	PCV chemotherapy + radiation	PCV is often important in oligodendroglioma treatment planning, especially when 1p/19q codeletion is present.
IDH-mutant glioma	Vorasidenib	This is a targeted option for selected IDH-mutant gliomas, not a general substitute for temozolomide. NCI lists vorasidenib among drugs approved for brain tumors. (Cancer.gov)
BRAF V600E-mutant glioma	Dabrafenib + Trametinib	Used only when the tumor has a suitable BRAF mutation. NCI lists dabrafenib and trametinib among approved brain tumor drugs. (Cancer.gov)
Temozolomide intolerance	Lomustine, PCV, Bevacizumab, carmustine implant, radiation-based treatment, clinical trial	Choice depends on blood counts, liver function, infection risk, prior radiation, and tumor genetics.

Chemotherapy alternatives:

• Lomustine
• Carmustine
• Carmustine implant / Gliadel wafer
• Procarbazine
• Vincristine
• PCV regimen

Targeted / biologic options in selected cases:

• Bevacizumab
• Vorasidenib
• Dabrafenib + Trametinib
• Imatinib Mesylate

Non-drug treatment options:

• Surgery
• Radiation therapy
• Tumor Treating Fields
• Clinical trial therapy

Important Safety Note

Temozolomide is used for serious brain tumors. The best alternative depends on tumor diagnosis, grade, recurrence, MGMT methylation, IDH mutation, BRAF mutation, 1p/19q codeletion, prior radiation, blood counts, liver function, and overall fitness. Do not stop or switch temozolomide without a neuro-oncologist’s guidance.

Storage Instructions

• Store at room temperature, generally between 68°F and 77°F (20°C to 25°C), unless otherwise directed on the label.
• Keep the medication in its original container, protected from excess moisture and light.
• Do not open or crush the capsules; handle the intact container according to the pharmacy’s instructions, as temozolomide is a chemotherapy medication requiring special handling.
• Keep out of reach of children and pets at all times, ideally in a locked or secured location.
• Do not use temozolomide past its expiration date, and dispose of unused medication according to pharmacist or local hazardous medication disposal guidelines rather than discarding it in household trash.

Disclaimer

This page is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Patients must consult a licensed oncologist, neuro-oncologist, or other relevant medical specialist before starting, changing, or stopping treatment with temozolomide. Treatment decisions must be based on a full clinical evaluation by a qualified specialist.